ProfileGDS5822 / ILMN_1256817
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 98% 93% 94% 98% 88% 92% 92% 95% 96% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 12612.498
GSM1276600PDAC Late Ablation Control 2836.693
GSM1276601PDAC Late Ablation Control 31171.294
GSM1276602PDAC Late Ablation 12287.998
GSM1276603PDAC Late Ablation 2378.588
GSM1276604PDAC Late Ablation 3694.392
GSM1303940PDAC Late Ablation_anti-CTLA4 1674.592
GSM1303941PDAC Late Ablation_anti-CTLA4 21452.395
GSM1303942PDAC Late Ablation_anti-CTLA4 31619.296